Duloxetine vs Venlafaxine: side-by-side comparison
Duloxetine and Venlafaxine belong to the same class (Serotonin-norepinephrine reuptake inhibitor (SNRI)). They share therapeutic approach but differ in mechanism nuances, half-life, side-effect profile and available formulations. This comparison summarises what is common and where they diverge.
| Property | Duloxetine | Venlafaxine |
|---|---|---|
| Therapeutic class | Serotonin-norepinephrine reuptake inhibitor (SNRI) | Serotonin-norepinephrine reuptake inhibitor (SNRI) |
| CAS | 116539-59-4 | 93413-69-5 |
| ATC | N06AX21 | N06AX16 |
| Molecular weight | 297.41 g/mol | 277.40 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Both are in the Serotonin-norepinephrine reuptake inhibitor (SNRI) class, giving them a common pharmacological architecture and many shared safety and management points. Choice within the class comes down to mechanism nuances, half-life, side-effect profile and individual response.
Key differences
Differences within the Serotonin-norepinephrine reuptake inhibitor (SNRI) class are what matter in practice: half-life, route of administration, equivalent doses, specific interactions, predominant side-effect profile and accumulated clinical experience. This page frames them; the prescribing information gives quantitative detail.
Mechanisms compared
Duloxetine: Duloxetine inhibits the reuptake of both serotonin and norepinephrine at the synapse, with weaker effect on dopamine. Venlafaxine: Venlafaxine inhibits the reuptake of both serotonin and norepinephrine at the synapse, with a dose-dependent profile: at low doses (≤75mg) it acts mainly on serotonin like an SSRI, while at higher doses (150mg+) the nore…
Indications compared
Duloxetine: Duloxetine is approved for major depressive disorder, generalised anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, chronic musculoskeletal pain (back pain, osteoarthritis) and stress urinary incontin… Venlafaxine: Venlafaxine is approved for major depressive disorder, generalised anxiety disorder, social anxiety disorder and panic disorder.
Safety profile
Duloxetine: Common adverse effects include nausea (most prominent in the first 1–2 weeks), dry mouth, headache, fatigue, sleep disturbance and sexual dysfunction. Venlafaxine: Common adverse effects include nausea (most prominent in the first weeks), dry mouth, sleep disturbance, increased sweating, headache and sexual dysfunction.
Frequently asked questions
Is Duloxetine better than Venlafaxine? ▾
Neither is universally better. Duloxetine and Venlafaxine share the Serotonin-norepinephrine reuptake inhibitor (SNRI) class but differ in half-life, mechanism nuances and side-effect profile. The choice depends on the patient and the prescriber.
Can Duloxetine and Venlafaxine be combined? ▾
Combining two ingredients from the same Serotonin-norepinephrine reuptake inhibitor (SNRI) class is uncommon and, in most cases, adds no benefit over one at an appropriate dose. The decision is always the prescriber's.
Do they have the same side-effect profile? ▾
Partly yes — they share many Serotonin-norepinephrine reuptake inhibitor (SNRI) class effects, with nuances by mechanism and dose. The prescribing information lists differences.
Products with Duloxetine
Products with Venlafaxine
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.